Introduction {#S1}
============

A biofilm represents a syntrophic microbial community in which microbes adhere to each other and to a biotic or abiotic surface ([@B71]). Biofilms are usually formed by a variety of microorganisms, and mixed-species biofilms can cause persistent infections in medicine, drinking water pollution in water reservoirs, and food spoilage in the industry ([@B75]; [@B17]; [@B76]). Approximately 60--80% of microbial infections are associated with mixed-species biofilms ([@B79]). In some disease situations, multispecies biofilm infections lead to worse outcomes than monospecies infections ([@B78]; [@B38]). For example, patients with cystic fibrosis present a more rapid decline of lung function when co-infected with *Pseudomonas aeruginosa* and *Staphylococcus aureus* than those who are infected by only one species ([@B49]; [@B48]). Therefore, controlling mixed-species biofilms has been one of the hot research areas in recent years.

Microbial cells within a mixed-species biofilm present increased resistance to environmental conditions, such as antibiotic treatment, oxidative stress, and nutrient starvation, in comparison with planktonic cells ([@B4]). For the last decade, most investigations have been aimed at controlling biofilms by using different strategies ([@B16]), including bacteriophage therapy, biofilm matrix-active enzyme treatment, bacteriocin management, and using new antibiofilm compounds (such as essential oils, phenolic acids, curcumin, and polyphenolic components) ([@B72]; [@B84]). However, these techniques are not considered as perfect biofilm eradication strategies because of their potential to eventually contaminate the treated surface or lead to environmental pollution ([@B27]). Furthermore, many studies have warned that the complete elimination of mixed-species biofilms may not be achieved by using one treatment method only, and comprehensive measures are often required ([@B13]).

Plasma is one of the four fundamental states of matter in nature ([@B73]). The "cocktail" constituents of plasma, including molecules and neutral atoms, charged particles, metastable radicals, and photons, play synergistic functions in microbial inactivation ([@B26]). In recent years, cold atmospheric plasma (CAP) has been extensively investigated for its potential as an alternative treatment in wound healing, dental cure, oncological therapy, and food decontamination ([@B71]; [@B37]; [@B15]). Significant progress has been made in controlling mixed-species biofilms with CAP, which is considered a rapid, environmentally friendly, energy saving, and versatile antimicrobial technology ([@B73]). The present review focuses on the potential of CAP treatment to combat biofilms especially mixed-species biofilms, which are the dominant form of microorganisms existing in nature.

Resistance of Mixed-Species Biofilms {#S2}
====================================

The high resistance and physiological change in microorganisms due to external treatments from hostile environments are nerve-wracking issues in biofilm control ([@B27]). Microbial cells in biofilms are embedded in extracellular polymeric substance (EPS), which makes up approximately 90% of the biofilm volume. Microorganisms cooperate and compete with each other to achieve the overall fitness in the consortia. EPS protects microbial cells from inactivation through host immunity and environment factors, such as antimicrobial agents, chemical disinfectants, and UV radiation ([@B69]).

Microbial Interactions in Mixed-Species Biofilms {#S2.SS1}
------------------------------------------------

The physiological events during the cell proliferation and the biofilm maturation of mixed-species communities are complex ([@B17]). One common interaction among microorganisms in mixed-species biofilms is the competition for nutrient acquisition and space occupation. [@B62] showed that indigenous microbial cells in the runoff fluids of fresh salmon compete with *Listeria monocytogenes* for nutrients in mixed-species biofilms, resulting in a remarkable reduction in the number of *L. monocytogenes* cells compared with that in monospecies biofilms. Toxic substances, such as bacteriocins, hydrogen peroxide, organic acids, and enzymes, which are secreted by some microbial species provide competitive advantages over other species within mixed-species biofilms ([@B68]). The biofilm formation of *Candida albicans* can be inhibited when co-cultured with *P. aeruginosa* through the secretion of virulence factors ([@B3]). *Lactobacillus* metabolites can kill *L. monocytogenes* in mixed-species biofilms by using hydrogen peroxide, lactic acid, and bacteriocin ([@B82]).

The cooperative interactions are widely existent when all members in the consortia benefit each other during biofilm formation ([@B66]; [@B51]). The cooperative microbial interactions in mixed-species biofilms may be based on the enhancement of the adhesion of the secreted matrix produced by partners or through metabolic cross-feeding by the products that promote the growth of other members. The dual-species biofilms formed by *Lactococcus lactis* and *Pseudomonas fluorescens* result in increased bacterial adhesion by up to 20,000- and 100-fold, respectively ([@B84]). The authors proposed that the poor biofilm former *L. lactis* may benefit from the enhanced adhesion ability supported by the quick matrix-producing *P. fluorescens*. By contrast, some metabolites that originated from *L. lactis* may be utilized as nutrient sources by *P. fluorescens*. [@B52] showed that the mixed-species biofilm formed by *Escherichia coli*, *Salmonella enterica*, and *L. monocytogenes* are facilitated by *Ralstonia insidiosa*, which provides a microenvironment for microbial accumulation and growth in nutrient-limited environments through its highly efficient nutrient utilization and cell proliferation. Given the complex microbial interactions, a mixed-species biofilm often achieves substantially more biomass than a monospecies biofilm without the need to input more nutrients ([@B67]).

Enhanced Resistance Presented by Mixed-Species Biofilms {#S2.SS2}
-------------------------------------------------------

The resistance of microbial biofilms is reinforced in a synergistic manner after the formation of mixed-species communities ([@B6]). EPS plays a critical role in biofilm resistance enhancement ([@B69]). The production of EPS, such as exopolysaccharide, is increased in biofilm cells compared with their planktonic counterparts. The constitution of EPS also varies markedly depending on the environmental elements and the bacterial species involved ([@B18]). The EPS of *S. aureus* possesses proteins, eDNA, and polysaccharides ([@B69]), whereas the biofilm matrix of *P. aeruginosa* can produce at least three polysaccharides, namely, alginate, Psl, and Pel ([@B18]). Studies have proven that EPS can act as cement to enhance initial adhesion and promote bacterial accumulation on a surface ([@B74]). Components of the biofilm matrix may also act as a reserve source of energy facilitating the nutrient accumulation in the microenvironment ([@B16]). Therefore, methods that destroy the EPS are effective for biofilm prevention. For instance, eDNA is widely present in biofilms and DNase treatment is currently considered effective in curing biofilm infections ([@B37]). A study reported that a SigB(Q225P) mutation can enhance the *S. aureus* biofilm by downregulating the expression of the *nuc* gene, and the biofilm is evidently reduced after DNase I treatment compared with the untreated strain ([@B50]).

Besides the protection role of EPS, microbial interactions in mixed-species biofilms also may contribute to resistance enhancement. The organization of microorganisms within mixed-species biofilms is finely controlled for the fitness contribution of the whole consortium ([@B51]). Single-species biofilms lack commensal interactions between species, whereas mixed-species biofilms can form an intermixing structure ([@B84]). The bacterial species may be present promiscuously throughout the community or as a layered structure, in which one species is in the bottom layers and the other one grows in the top layers. These spatial structures may be attributed to the survival rate of individual species within the mixed-species biofilms as a result of cooperative or competitive interactions ([@B58]). In a dual-species biofilm infection, *P. aeruginosa* exhibits excellent colonizing capacity and often forms the basic biofilm structure, while *K. pneumoniae* usually takes shape as a tower-like structure at the biofilm top due to its higher growth rate ([@B9]). The interaction between *P. aeruginosa* and *K. pneumoniae* in the biofilms can enhance their resistance to the treatment of antimicrobial agents.

Mechanisms Underpinning the Enhanced Resistance of Mixed-Species Biofilms {#S2.SS3}
-------------------------------------------------------------------------

The primary mechanisms of enhanced resistance within mixed-species biofilms are not entirely clear due to the change in the composition of the biofilm matrix and the enhanced microbial interactions in the consortia. Several speculations regarding the enhanced resistance in mixed-species biofilms have been proposed. First, some species may protect others by their aggregation with other strains within the three-dimensional structure spatially arranged by certain species ([@B46]). *Vibrio parahaemolyticus* is often located on the top layers of multispecies biofilms because of its competitive advantage, and its minimum inhibitory concentration against antibiotics is remarkably decreased when co-cultured with *L. monocytogenes* ([@B8]). The second mechanism involves the matrix of a mixed-species biofilm. The chemical interactions between the EPS produced by distinct species may result in a thick matrix, which varies in accordance with the microbial species involved and the changes in environmental condition ([@B18]). The thickness of the matrix is suggested to play functions in mixed-species biofilm resistance by blocking the reach of the risk factors to the lower layers of active microbes ([@B25]). EPS has also been experimentally proven to bind to antibiotics with positive charges, such as aminoglycosides, blocking their antimicrobial effects on microbes ([@B16]). In the mixed-species biofilms formed by *Staphylococcus epidermidis* and *C. albicans*, the EPS derived from *S. epidermidis* can protect *C. albicans* by arresting the penetration of antifungal drugs, such as fluconazole ([@B10]).

In addition, the temporary alterations in microbial neighbors contribute to enhanced mixed-species biofilm recalcitrance. A species settling down in a mixed-species biofilm can alter the physiology of neighboring species by interspecies interactions ([@B32]), such as antibiotic resistance gene exchange, antibiotic-inactivated enzyme transfer, quorum-sensing signal-induced gene expression changes, and metabolite-mediated electron transport chain inhibition ([@B30]; [@B61]). For example, carbapenemase resistance gene-carried plasmid can be transferred from *E. coli* to either *Acinetobacter baumannii* or *P. aeruginosa* in mixed-species biofilms but is not observed in the planktonic state of these organisms ([@B77]; [@B65]). The 2-heptyl-4-hydroxyquinolone N-oxide secreted by *P. aeruginosa* can alter the susceptibility of *S. aureus* strains within mixed-species biofilms to several antibacterial agents, such as vancomycin, aminoglycosides, and chloroxylenol ([@B61]). The fungus *C. albicans* can induce vancomycin resistance of *S. aureus* during mixed-species biofilm formation ([@B31]). These possible mechanisms can result in a 100- to 1000-fold more resistance for mixed-species biofilms to antibiotics than their planktonic cells and therapeutic challenge of persistent biofilm infections in the host ([@B33]). Therefore, interfering with the aforementioned mechanisms may be a promising strategy for the control of biofilms in nature and diseases.

Cold Atmospheric Plasma {#S3}
=======================

Cold atmospheric plasma is an emerging antimicrobial strategy that could improve biofilm eradication ([@B40]; [@B27]). The word "plasma" was first used by Irving Langmuir in 1928 to describe quasineutral ionized or partially ionized gas generated by heating or through the application of a strong electromagnetic field ([@B73]). Plasma is divided into thermal (at least 15,000 K) and non-thermal (less than 340 K) plasmas in accordance with the temperature of ionized gas. Non-thermal plasma, which is called CAP, is a partially ionized gas with a temperature generally close to room temperature ([@B21]). The systems of CAP can produce numerous species of active ingredients, such as positive and negative ions, neutral atoms (e.g., atomic oxygen and ozone), reactive molecules (e.g., superoxide and oxides of nitrogen), metastable radicals (e.g., OH and NO), and photons (e.g., UV). These components can work synergistically to kill microorganisms and also destroy the matrix of biofilms ([@B37]).

Application-Oriented CAP Devices {#S3.SS1}
--------------------------------

The effectiveness of plasma may be dose-dependent, which depends on plasma source allocation, working gas supply, and biological target composition ([@B73]). Currently, there is no single prototype that can be used for all applications. The most widely used plasma devices for biological applications are dielectric barrier discharges (DBDs) and atmospheric pressure plasma jets (APPJs) ([Figure 1](#F1){ref-type="fig"}). The characteristics of DBD and APPJ are listed in [Table 1](#T1){ref-type="table"}. The defining features of DBDs and APPJs are the designs of dielectric material between the electrodes. DBD devices generally have electrode gaps ranging from tens of micrometers to a few centimeters and operate at frequencies of 50--500 kHz and voltage of tens of kilovolts. DBD devices, which are more suitable in the treatment of massive surfaces and large quantity of samples of varied shapes and sizes, are used in several fields, such as food industry ([@B73]). In contrast with DBDs, APPJs are beneficial to use for the direct treatment of target objects ([@B27]). As such, the application of APPJ is advantageous in medicine, wherein APPJ may be used in localized decontamination, wound healing, and cancer therapy.

![Schematic diagram of the typical configurations of CAP device. **(A)** The dielectric barrier discharge system. **(B)** The atmospheric plasma jet system.](fmicb-11-01000-g001){#F1}

###### 

Summary of comparable characteristics of DBD and APPJ plasmas.

  Compared items        DBD plasma                                                                           APPJ plasma                                                                     References
  --------------------- ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------- ------------
  Flowing working gas   Minimum or not required                                                              Required                                                                        [@B73]
  Plasma volume         Large                                                                                Small                                                                           [@B73]
  Plasma production     Burns between flat electrodes with imposed AC, separated by a dielectric insulator   Ionizes the carrier gas (Ar, He, Air) by high-frequency electric voltage        [@B45]
  Applied range         Usually an enclosed device for *ex vivo* or *in vitro* applications                  A versatile jet configuration used for *in vivo* and *in vitro* modifications   [@B20]
  Applied to surfaces   The surface is required to be a part of the high-voltage electrical circuit.         Not required                                                                    [@B60]
  Applied area          Expose large area                                                                    Strike only a small target area                                                 [@B73]

Inactivation of Microorganisms Upon CAP Treatment {#S3.SS2}
-------------------------------------------------

Cold atmospheric plasma is a versatile strategy for microbial inactivation. The application of CAP for the prevention and eradication of mixed-species biofilms includes two aspects: the direct and indirect applications of CAP for biofilm destruction ([@B19]). The indirect way is done by first applying CAP on biotic or abiotic surfaces, which are then used to control biofilm formation, or by first activating water with CAP and treating the biofilm by using plasma-activated water ([@B63]; [@B87]). The first investigation of bacterial inactivation by CAP was performed by imposing a voltage of 300 V to produce plasma by ionization of air ([@B43]). In a further study, a high voltage (20 kV/cm) was imposed on four electrodes to treat *Saccharomyces cerevisiae* or Bacillus subtilis (formerly Bacillus natto), and cell destruction was observed ([@B56]). A set of plasma species can coordinate to inactivate microorganisms. Some species, such as molecules and neutral atoms, can break the bonds in the peptidoglycan structure of Gram-positive bacteria ([@B86], [@B85]), whereas others may lead to the lipid peroxidation of the Gram-negative bacterial membrane ([@B39]). After the disruption of the bacterial cell wall, reactive oxygen (ROS) or reactive nitrogen (RNS) species penetrates the bacteria to damage further the intracellular protein and genomic DNA ([@B55]).

Several common observations have been achieved in the bacterial inactivation with CAP. First, Gram-positive bacteria are less sensitive to CAP treatment than Gram-negative bacteria, which is probably due to the thick and tough peptidoglycan layers of Gram-positive bacteria ([@B54]; [@B59]). [@B64] reported that the cell disruption of *E. coli* under low-temperature plasma treatment is more serious than that of *S. aureus*. The antimicrobial effect of CAP was also stronger in *A. baumannii* and *Salmonella* Typhimurium (Gram-negative strains) than in *S. aureus* (Gram-positive isolate) ([@B28]; [@B34]). However, Gram-positive *Enterococcus faecalis* presented higher overall susceptibility to CAP treatment compared with *P. aeruginosa*, and the mechanism underlying *E. faecalis*' high sensitivity to CAP processing is interesting and is worth further investigation. Second, vegetative bacterial cells are more susceptible to plasma sterilization than their spore counterparts ([@B60]). Lastly, the complete eradication of bacterial biofilm requires a much longer treatment duration than killing its planktonic counterparts ([@B55]).

The mechanisms participating in CAP inactivation are considered complicated due to the numerous species in plasma. CAP may have numerous targets in bacterial cells, including cell wall, cell membrane, genomic DNA, and intracellular proteins ([@B81]; [@B55]). Several plasma--cell interactions have been involved in the bactericidal effect of CAP. One of these interactions is the mechanical etching role performed by the atomic and molecular radicals of CAP, resulting in pore formation and cell erosion on the polymeric surface of microorganisms ([@B29]; [@B34]). Another interaction is the photodesorption implemented by UV radiation, which results in the subsequent chemical bond breakage of bacterial organic macromolecules ([@B80]; [@B5]). The third interaction is the DNA damage triggered by reactive species ([@B10]; [@B70]), and the last interaction is the oxidative damage of bacterial proteins, polysaccharides, and lipids caused by ROS and RNS ([@B14]; [@B36]). As a result, Gram-negative bacteria, such as *P. aeruginosa*, often exhibit visible morphological changes in cell shape, whereas minor or inconspicuous morphological deformities are observed in Gram-positive bacteria, such as *S. aureus* and *E. faecalis*, after the CAP procedure ([@B59]; [@B83]).

Microbial Factors Influencing the Efficacy of CAP Treatment {#S3.SS3}
-----------------------------------------------------------

The efficacy of CAP treatment against biofilms formed by certain microorganisms varies depending on microbial type, growth phase, produced matrix, biofilm thickness, and process factors ([@B73]). The bacterial envelope structure plays important roles in microbial defense for CAP processing ([@B54]). Gram-positive bacteria have a relatively thick cell wall (20--80 nm) composed of peptidoglycan, whereas Gram-negative bacteria have a thin cell wall (3--5 nm) but possess an additional outer membrane embedded by lipopolysaccharide and several pores. These differences in the microbial envelope can confer the different sensitivities of bacterial cells to CAP treatment. [@B54] revealed that the bacterial cell wall thickness is correlated with the log10 colony forming unit (CFU) reduction after different durations (1, 3, or 10 min) of CAP treatment. Moreover, *P. aeruginosa* exhibits more resistance to CAP when co-cultured with *S. epidermidis* as dual-species biofilms than that as a monospecies biofilm. [@B57] reported the biphasic bacterial effect of ROS-dominated CAP, generated ROS-dominated gas-phase regimen with a low power discharge (8 W), and revealed that mixed-species biofilms containing *P. aeruginosa*, *S. aureus*, *E. faecalis*, and *K. pneumoniae* present a biphasic bacterial killing under ROS exposure. In the four-species biofilms, *P. aeruginosa* was much less susceptible to ROS-dominated plasma and presented a more gradual reduction in viable count across the 240 s of exposure (less than 3 log10 CFU), whereas the three other species were more susceptible to ROS plasma with more than 3 log reduction in viable cell count, showing a quicker reduction between 60 and 120 s of plasma treatment.

Formation of the viable but non-culturable (VBNC) state of microorganisms also contributes to CAP resistance. [@B1] showed the presence of inactivated bacterial cells or their VBNC state after CAP treatment through quantitative polymerase chain reaction amplification targeting the 16S rRNA. [@B47] reported that a level of 7.4 to 7.6 log10 CFU/ml of *S. aureus* VBNC cells can be induced after 8.1 to 24.3 kJ CAP treatment. The authors also found that most energy-dependent physiological activities are arrested, while the oxidative stress response-related pathways are obviously upregulated in *S. aureus* VBNC state. In addition, genome comparison between control cells and survivors in transposon-mutated *S. aureus* biofilms has shown that the genes involved in the synthesis of the pigment staphyloxanthin are associated with resistance to CAP treatment ([@B53]). A recent study showed that CAP-processed *S. aureus* cells present decreased pigment phenotype, and the deletion of the staphyloxanthin biosynthetic genes *crtM* and *crtN* confers Newman-Δ*crtM* and Newman-Δ*crtN*, but not Newman-Δ*crtO*, with increased sensitivity to CAP treatment ([@B83]). These data suggest that the yellow intermediates of *S. aureus* pigment's biosynthetic pathway are important factors for the resistance of *S. aureus* against CAP inactivation. The reason may be the antioxidant property of the golden carotenoid pigment for deactivating ROS and helping bacteria evade ROS killing ([@B7]). Other antioxidant molecules produced by microorganisms, such as pyocyanin of *P. aeruginosa*, may also protect bacteria from CAP treatment. The anti-CAP roles of antioxidant molecules need further investigation.

Application of CAP on Mixed-Species Biofilm Control {#S4}
===================================================

The pioneering work regarding the possible inactivation of mixed-species biofilms through CAP has been conducted by [@B11], who showed that the CAP deposition on mixed-species biofilms formed by *S. epidermidis*, *P. fluorescens*, and *S.* Typhimurium results in the decrease of 56.5% bacterial attachment and 72.2% biofilm formation. The authors concluded that the CAP deposition of polyethylene glycol-like structures may be useful for food processing and medical practice to reduce bacterial contamination. [@B55] reviewed the advances in the decontamination of biofilm-associated bacteria by using CAP. [@B71] recently reviewed the use of CAP as a tool for decontamination and disinfection, such as in microorganism inactivation, pollutant removal, surface modification, food preparation, biofilm degradation, wound therapy, nosocomial infection prevention, cancer treatment, prion inactivation, and apoptosis initiation. [@B27] presented an overview of plasma instrumentation and summarized the studies of plasma on biofilms by mostly using monospecies biofilms.

Medical Applications {#S4.SS1}
--------------------

Mixed-species biofilms represent the primary environment of most pathogens in the clinical setting. The normal ecological environment of microbial consortia that often coexist with its dwelling host may be easily disrupted by invading pathogens, which can outcompete healthy normal flora during their growth and transform the commensal consortia into pathogenic biofilms ([@B79]). Many pathogens often colonize joint replacements, heart valves, and metal or plastic implants to form mixed-species biofilms, which cause life-threatening diseases ([@B40]). [@B22] conducted a multicenter retrospective cohort study on patients with complicated urinary tract infections from 20 hospitals in eight countries and found that 42.2% (341/807) of the patients have catheter-associated urinary tract infections. Another study conducted in Singapore reported that about 14.7% (69/470) of the patients who underwent peritoneal dialysis have been subjected to catheter removal due to infection ([@B44]). Indwelling medical device-related and catheter-associated infections can be caused by mixed-species biofilms, and many pathogens involved in biofilm formation can be cultured ([Figure 2](#F2){ref-type="fig"}). Mixed-species biofilm infections have raised great concerns and are difficult to cure ([@B2]).

![Peritoneal dialysis catheter-associated infections caused by mixed-species biofilm. **(A)** The peritoneal dialysis catheter was filled with thick pus. **(B)** Several bacterial species derived from catheter-infection pus were grown on sheep blood agar after being cultured at 37°C for 16 h postinoculation.](fmicb-11-01000-g002){#F2}

As a novel antimicrobial strategy, applications of CAP in fighting mixed-species biofilms have been investigated ([Table 2](#T2){ref-type="table"}). In an early work, [@B42] demonstrated the role of CAP in killing multispecies human saliva biofilms grown on titanium disks *in vitro* and found a 5.67 reduction in log10 CFU after 10 min of DBD argon plasma treatment. The authors concluded that the treatment of mixed-species dental biofilms on titanium disks by using CAP resulted in a reduction of 1.50 log10 CFU for saliva biofilm and that CAP is more efficient than chlorhexidine digluconate rinse. Koban's group also evaluated the synergistic effects of CAP and disinfectants against multispecies dental biofilms and reported that the combination of disinfecting agent NaOCl or hydrogen peroxide with CAP achieves a higher level of CFU reduction than each agent alone ([@B41]). [@B12] confirmed the synergistic effect of CAP with 2% chlorhexidine digluconate on mixed-species biofilms by incubating polyspecies bacteria from human dental root canal infections on sterile bovine dentin disks. [@B10] reported the role of CAP on pathogenic oral biofilms constituted by *C. albicans* and *S. aureus*. In their study, the dual-species biofilms presented a considerable log10 CFU/ml reduction (1.52 for *C. albicans* and 1.23 for *S. aureus*) after 60 s of CAP treatment. Colony counting, confocal laser scanning microscopy, and scanning electron microscopy revealed reduced viability and the alteration of the morphology of the microorganism/biofilm in plasma group in comparison with those in the negative control. Importantly, low cytotoxicity and high viability in the oral epithelium were observed after treatment with CAP. Further study showed no sign of necrosis in the plasma-treated epithelium, and cell proliferation was well maintained, indicating that CAP is a safe approach to eliminate pathogenic oral biofilms ([@B10]).

###### 

Direct CAP activity against mixed-species biofilms.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Microorganisms/biofilms                                                                                   Plasma source                                       Working gas                                    Antimicrobial effect (processing duration)                                                                                 References
  --------------------------------------------------------------------------------------------------------- --------------------------------------------------- ---------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- ------------
  Saliva mixed-species biofilms                                                                             Plasma jet (27 MHz)\                                Argon\                                         1.42 reduction in log10 CFU (10 min) 5.67 reduction in log10 CFU (10 min)                                                  [@B42]
                                                                                                            DBD plasma (40 kHz, 10 kV)                          Argon                                                                                                                                                                     

  Dental root canal biofilms                                                                                Plasma jet (8 kV, 8 kHz)                            Helium/oxygen + 2% chlorhexidine digluconate   76% dead of biofilm volume (5 min)                                                                                         [@B12]

  Multispecies subgingival biofilms                                                                         Plasma jet + H~2~O~2~ (kINPen 09, 27 MHz)           Argon                                          3.41 ± 0.86 reduction in log10 CFU (10 min)                                                                                [@B41]

  *Salmonella* Typhimurium mixed with cultivable indigenous microorganisms                                  Plasma jet (1200∼1250 mWs/cm^2^)                    Air                                            ∼4.6 reduction in log10 CFU/cm^2^ (60 s)                                                                                   [@B35]

  *Candida albicans* and *Staphylococcus aureus*                                                            Plasma jet (220 V, 8 W)                             Argon                                          Log10 CFU reduction for *C. albicans* (1.52 ± 0.18) and S. *aureus* (1.23 ± 0.21) (60 s)                                   [@B10]

  *Pseudomonas* aeruginosa and *Staphylococcus epidermidis*                                                 Plasma jet                                          Argon                                          Log10 CFU reduction for *P. aeruginosa* (2.6 ± 0.4) and *S. epidermidis* (1.4 ± 0.5) (10 min)                              [@B54]

  *Pseudomonas aeruginosa*, *Staphylococcus aureus*, *Klebsiella pneumoniae*, and *Enterococcus faecalis*   DBD plasma 8 W (ROS-dominated)\                     Air\                                           Log10 CFU reduction for *P. aeruginosa* (2.3), *S. aureus* (2.8), *K. pneumonia* (3.8), and *E. faecalis* (2.9) (120 s)\   [@B57]
                                                                                                            \                                                   \                                              Log10 CFU reduction for *P. aeruginosa* (4.2), *S. aureus* (3.3), *K. pneumonia* (4.2), and *E. faecalis* (3.3) (60 s)     
                                                                                                            34.5 W (RNS-dominated)                              \                                                                                                                                                                         
                                                                                                                                                                Air                                                                                                                                                                       

  Complex multi-species biofilms of municipal water systems                                                 Plasma jet (58 W/cm^2^)                             Helium                                         Fall from 122 ± 17 μm to 55 ± 13 μm in biofilm thickness (15 min)                                                          [@B75]

  *Listeria monocytogenes* and *Salmonella* Typhimurium                                                     DBD plasma (6.5 kV, 15 kHz)                         Helium                                         2.8 reduction in log10 CFU/cm^2^ (15 min)                                                                                  [@B24]

  *Listeria monocytogenes* and *Pseudomonas fluorescens*                                                    DBD plasma (80 kV)                                  Air                                            4.2 ± 0.2 reduction in log10 CFU (60 s)                                                                                    [@B63]

  Mixed-species water biofilms                                                                              Underwater DBD microplasma bubbles (4.0 kV, 40 W)   Air                                            83% reduction in the existing biofilm load (15 min)                                                                        [@B87]

  *Listeria monocytogenes* and *Salmonella* Typhimurium                                                     DBD plasma (4 kV, 12 kHz)                           Air\                                           2.40 ± 0.31 reduction in log10 CFU (30 min)\                                                                               [@B23]
                                                                                                                                                                \                                              2.95 ± 0.23 reduction in log10 CFU (30 min)                                                                                
                                                                                                                                                                Helium                                                                                                                                                                    
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Food Industrial Applications {#S4.SS2}
----------------------------

Cold atmospheric plasma has also been proven to be a promising strategy for the control of multispecies biofilms formed by foodborne pathogens ([@B23]; [@B34]). The cultures of *S.* Typhimurium mixed with cultivable indigenous microorganisms exhibited greater resistance to cold oxygen plasma (COP) compared with monoculture biofilms on fresh iceberg lettuce ([@B35]). However, a reduction in log10 CFU/cm^2^ by approximately 4.6 was achieved in mixed cultures after COP treatment, and a notable shift in the colony type of *S.* Typhimurium from smooth to rugose was observed for biofilms on stainless-steel coupons even after 10 s of processing procedure with COP. By contrast, 5 min of COP treatment did not achieve any morphological shift in *S.* Typhimurium mixed biofilms on lettuce coupons. This difference may be ascribed to the penetration of COP to biotic and abiotic surfaces because COP does not penetrate the lettuce. [@B63] showed that the bacterial biofilm populations of *L. monocytogenes* and *P. fluorescens* on abiotic surfaces treated with autologous conditioned plasma of high voltage (80 kV) has yielded non-detectable levels after 120 s of treatment. The inoculation on lettuce required an extended time to complete the eradication of mixed-species biofilms, and *L. monocytogenes* and *P. fluorescens* reduced by 2.2 and 4.2 log10 CFU/ml, respectively, after 120 s of contained treatment. [@B23] reported the air-based CAP treatment of dual-species biofilms formed by *L. monocytogenes* and *S.* Typhimurium, and a result of log10 CFU/cm^2^-reductions ranging between 1.5 and 2.5 was observed. The inactivation efficacy of CAP treatment may depend on the biofilm population type, but not the working gas supplied ([Table 2](#T2){ref-type="table"}).

Water-Treatment Applications {#S4.SS3}
----------------------------

Mixed-species biofilms also grow and thrive in drinking water systems and usually result in human health concerns. [@B75] treated the simulated polymicrobial drinking water biofilms with a 9 × 9 array of plasma jet, and results showed that all biofilms tested vanished in 20 min of CAP exposure. Confocal laser scanning microscopy revealed that the number of active cells in mixed-species biofilms was reduced by more than 93% after 15 min of CAP treatment. [@B87] emphasized the importance of biochemically reactive species from plasma in the eradication of multispecies water biofilms and created a microplasma-bubble reactor to generate underwater microplasma bubbles that served as transport vehicles for delivering plasma reactive species to the water biofilm sites. The underwater microplasma bubbles generated in an artificial fish tank could enhance the mass transfer of ROS and RNS (mostly nitric oxide) into water for applications, such as initiating biofilm dispersal and treating bacterial biofilms on the skin of infected fish.

The microplasma bubbles are considered to be effective for underwater biofilm eradication. When reaching the close vicinity of a water biofilm, the self-burst of microbubbles may produce pressure waves that can break up the EPS matrix of the biofilms. Such pressure waves can further induce the bursting of other yet-to-burst microbubbles like a chain reaction to keep on disrupting the biofilm matrix until the whole biofilm structure is collapsed ([@B87]). While the biofilm is dispersing, the resident microbial cells are exposed to bactericidal plasma-activated water carrying ROS and RNS. However, the fundamental features of plasma-liquid physics and chemistry are largely unknown and are worth further investigation.

Limitation of CAP on Mixed-Species Biofilm Control {#S4.SS4}
--------------------------------------------------

Most advantages of CAP process on multispecies biofilms have been accompanied by numerous limitations. The first obvious limitation is the weak penetrating capacity of plasma species into the deeper layers of mixed-species biofilms ([@B37]). The increased production of EPS in biofilms may impede CAP penetration and prevent the antimicrobial effect of CAP on microbial cells at the bottom of the biofilms. The resistance of microbial cells and mixed-species biofilms to CAP varies depending on the microbial species involved, the changes in environmental condition, and the composition of active species generated by CAP systems ([@B37]). The second limitation involves the nature and quantity of mixed-species biofilms to be sterilized. CAP sterilization in the food industry, for example, the treatment of bulky and irregularly shaped food, limited volume of the investigated material should be considered ([@B71]). The rough biofilm surfaces often protect microbial cells from CAP exposure, and result in CAP treatment failure ([@B73]). The third limitation involves the formation of VBNC microbial state. CAP treatment has been proven to induce the VBNC state of microbial cells, although the mechanisms underlying VBNC formation are obscure ([@B1]; [@B47]). The fourth limitation involves the servicing costs. Although the opening expenses and maintenance costs have been considerably decreased in CAP generated in ambient air, a CAP system that operates at low pressure usually requires high investment costs ([@B73]). Possible solutions should be investigated to counter these limitations before the translation of CAP into real-life applications.

Conclusion {#S5}
==========

Naturally existing biofilms are composed of varied microbial species. The biological characteristics of microbes were explored as part of mixed-species biofilms rather than in strain isolation. The resident microorganisms in a mixed-species biofilm cooperate and/or compete to access available spaces and nutrients. The current information on microbial interactions among mixed-species biofilms are mainly derived from cultural investigations of polymicrobial biofilms *in vitro*, and information on actual interactions in mixed-species biofilms formed *in vivo* are scarce. Most common diseases, such as indwelling medical device-related and catheter-associated infections, are caused by mixed-species biofilms rather than by isolated pathogens.

Mixed-species biofilms display greater resistance to external stressors, including antibiotics and disinfectants. The mechanisms underlying mixed-species biofilm's elevated resistance to environmental factors are still unclear. The increased EPS production and enhanced microbial interaction in multispecies communities contribute to this resistance. In recent years, much effort has been devoted to mixed-species biofilm control. The most striking strategy used for mixed-species biofilm eradication and prevention is CAP, which can produce many species of active ingredients to implement different microbicidal mechanisms. Accumulated studies have confirmed that CAP can deconstruct the mixed-species biofilm matrix and also kill microbial cells. CAP can be developed as an effective tool against mixed-species biofilms in the water supply system, food industry, and medical practice. However, the safety assessment for CAP applications is extremely limited, important, and worthy of study in the future.
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